journal article·2018-07

Fluorescent 2D WS2 Nanosheets Bearing Chemical Affinity Elements for the Recognition of Glycated Hemoglobin

Jin‐Kyoung Yang, Hye‐Rim Lee, In‐Jun Hwang, Hye‐In Kim, DaBin Yim, Jong‐Ho Kim

Advanced Healthcare Materials· Volume 7· Issue 14
Publisher page

Abstract

Abstract It is required to exfoliate and functionalize 2D transition metal dichalcogenides (TMDs) in an aqueous solution for biological and medical applications. Herein, the approach for the simultaneous exfoliation and functionalization of 2D WS2 nanosheets using boronic acid‐modified poly(vinyl alcohol) (B‐PVA) in an aqueous solution is reported, and the B‐PVA‐functionalized WS2 nanosheets (B‐PVA‐WS2) are exploited as a fluorescent biosensor for the detection of glycated hemoglobin, HbA1c. The synthetic B‐PVA polymer facilitates the exfoliation and functionalization of WS2 nanosheets from the bulk counterpart in the aqueous solution via a pulsed sonication process, resulting in fluorescent B‐PVA‐WS2 nanohybrids with a specific recognition of HbA1c. The fluorescence of the B‐PVA‐WS2 is quenched in the presence of HbA1c, whereas PVA‐functionalized WS2 (PVA‐WS2), not bearing boronic acid as a recognition moiety, shows no fluorescence changes upon the addition of the target. The B‐PVA‐WS2 is able to selectively detect HbA1c at the concentration as low as 3.3 × 10−8 m based on its specific fluorescence quenching.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 2D Materials and Applications · Advanced biosensing and bioanalysis techniques · Sulfur Compounds in Biology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering Hanyang University Ansan 426‐791 Republic of Korea

Funding

National Research Foundation of Korea · Ministry of Science ICT and Future Planning

References (40)

Show source-provided references
1. 10.1038/nnano.2012.19310.1038/nnano.2012.193 ↗
2. 10.1038/nchem.158910.1038/nchem.1589 ↗
3. 10.1016/j.mattod.2016.10.00210.1016/j.mattod.2016.10.002 ↗
4. 10.1063/1.477409010.1063/1.4774090 ↗
5. 10.1021/nn305275h10.1021/nn305275h ↗
6. 10.1002/adfm.20150089110.1002/adfm.201500891 ↗
7. 10.1126/science.119497510.1126/science.1194975 ↗
8. 10.1021/ac500209610.1021/ac5002096 ↗
9. 10.1002/adfm.20150386310.1002/adfm.201503863 ↗
10. 10.1002/adma.20160469110.1002/adma.201604691 ↗
11. 10.1002/adma.20110258410.1002/adma.201102584 ↗
12. 10.1021/acsnano.5b0722810.1021/acsnano.5b07228 ↗
13. 10.1021/acsami.5b1013610.1021/acsami.5b10136 ↗
14. 10.1021/jacs.5b0278010.1021/jacs.5b02780 ↗
15. 10.1088/2053-1583/aa796610.1088/2053-1583/aa7966 ↗
16. 10.1039/C7RA01680H10.1039/C7RA01680H ↗
17. 10.2337/dc11-S01110.2337/dc11-S011 ↗
18. 10.1056/NEJMoa090835910.1056/NEJMoa0908359 ↗
19. 10.1111/j.1464-5491.2007.02106.x10.1111/j.1464-5491.2007.02106.x ↗
20. 10.3343/alm.2013.33.6.39310.3343/alm.2013.33.6.393 ↗
21. Rohlfing C. · Clin. Chem. · 2002 · 48 · 111610.1093/clinchem/48.7.1116 ↗
22. Ou C.‐N. · Clin. Chem. · 1993 · 39 · 82010.1093/clinchem/39.5.820 ↗
23. 10.1039/C6LC00410E10.1039/C6LC00410E ↗
24. 10.1039/c2an16034j10.1039/c2an16034j ↗
25. 10.1039/c0cc00224k10.1039/c0cc00224k ↗
26. 10.1016/j.bios.2016.12.03810.1016/j.bios.2016.12.038 ↗
27. 10.1021/acs.analchem.6b0223410.1021/acs.analchem.6b02234 ↗
28. 10.1016/j.snb.2005.07.01110.1016/j.snb.2005.07.011 ↗
29. 10.1016/j.bios.2014.09.05810.1016/j.bios.2014.09.058 ↗
30. 10.1021/ac902364h10.1021/ac902364h ↗
31. 10.1021/ac203266a10.1021/ac203266a ↗
32. 10.1016/j.cca.2014.10.01910.1016/j.cca.2014.10.019 ↗
33. 10.1080/0003271810805547610.1080/00032718108055476 ↗
34. 10.3390/mi708013610.3390/mi7080136 ↗
35. 10.1002/adfm.20140000110.1002/adfm.201400001 ↗
36. 10.1089/pho.2012.342110.1089/pho.2012.3421 ↗
37. 10.4103/2229-5186.7934510.4103/2229-5186.79345 ↗
38. 10.1021/ja504276z10.1021/ja504276z ↗
39. 10.1021/acsnano.6b0149510.1021/acsnano.6b01495 ↗
40. John W. G. · Clin. Biochem. Rev. · 2007 · 28 · 163